ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

Army Breast Cancer Research Program Seeks Proposals

March 28, 1997

New Treatment Modalities For Endometrial Cancer

March 26, 2004

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005